PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...
For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...
WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest Enforcement ...
A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.
Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.
Integreon Global, working through its business units – Cryopak, DDL and NexKemia – enables pharmaceutical companies to protect product integrity while eliminating cold-chain packaging waste—by closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results